Barrow, Hanley, Mewhinney & Strauss Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$597M |
| 2 |
American International
AIG
|
+$328M |
| 3 |
Aramark
ARMK
|
+$292M |
| 4 |
Dominion Energy
D
|
+$278M |
| 5 |
Linde
LIN
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.28B |
| 2 |
Cardinal Health
CAH
|
+$454M |
| 3 |
PX
Praxair Inc
PX
|
+$256M |
| 4 |
Bank of America
BAC
|
+$231M |
| 5 |
Occidental Petroleum
OXY
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.94% |
| 2 | Healthcare | 15.79% |
| 3 | Energy | 12.54% |
| 4 | Industrials | 12.36% |
| 5 | Technology | 9.56% |
Similar funds
Barrow, Hanley, Mewhinney & Strauss's Q4 2018 Portfolio in Review
As of Q4 2018, Barrow, Hanley, Mewhinney & Strauss held 425 positions worth $51B, down 19% from $63B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barrow, Hanley, Mewhinney & Strauss withdrew a net $2.62B in Q4 2018, closing 77 positions and reducing 234 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $1.28B position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Barrow, Hanley, Mewhinney & Strauss opened a new position in Aramark worth $235M.
- Barrow, Hanley, Mewhinney & Strauss's largest Q4 2018 buy was Aramark: 11,251,667 shares worth $235M.
- Barrow, Hanley, Mewhinney & Strauss added most to Cigna in Q4 2018, an estimated $597M increase.
- Barrow, Hanley, Mewhinney & Strauss's biggest Q4 2018 reduction was Cardinal Health, cutting an estimated $454M.
- Barrow, Hanley, Mewhinney & Strauss fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $1.28B.
- Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 25% of its $51B portfolio in Q4 2018.
- Barrow, Hanley, Mewhinney & Strauss opened 26 new positions and closed 77 in Q4 2018.
- Barrow, Hanley, Mewhinney & Strauss's portfolio value fell 19% quarter-over-quarter to $51B.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2018, filed 13 Feb 2019.